Articles

Showing 6 articles

• Original Research

  Published 9 October 2026

  Tirzepatide versus other glucose-lowering therapies and risk of COPD exacerbations in patients with comorbid type 2 diabetes: a retrospective cohort study

  Wan-Hsuan Hsu · Yang-En Chan · Jheng-Yan Wu · Yao-Ming Chuang · Chia-Yu Kuo · Bo-Wen Shiau · Po-Yu Huang · Chih-Cheng Lai

  Frontiers in Pharmacology

  doi 10.3389/fphar.2026.1917340

• Brief Research Report

  Published 22 September 2026

  Cannabidiol/cannabigerol exposure and neuropathy-related outcomes after neurotoxic chemotherapy: a real-world cohort study

  Nicholas M. Graziane · Ajay Macherla · Matthew Giampetro

  Frontiers in Pain Research

  doi 10.3389/fpain.2026.1945720

• Original Research

  Published 21 September 2026

  Neuropsychiatric outcomes of ketamine and midazolam coadministration following vascular surgery: a multicenter database study

  Emily Lee · Albert Yang · Jason Chwa · Jody Chou

  Frontiers in Anesthesiology

  doi 10.3389/fanes.2026.1888859

• Original Research

  Published 7 August 2026

  Glucagon-like peptide-1 receptor agonist versus other anti-diabetic agents on patients with prostate cancer undergoing androgen-deprivation therapy

  Sheng-Chi Huang · Wan-Yu Cheng · Cheng-You Hou · Jheng-Yan Wu · Chih-Cheng Lai · Wen-Hsin Tseng

  Frontiers in Urology

  doi 10.3389/fruro.2026.1855180

• Original Research

  Published 21 January 2026

  Too soon to switch? Early TKI switching vs. continuous monotherapy: long-term outcomes in chronic myeloid leukemia

  Muluken Megiso · Chidiebube Ugwu · Elvis Obomanu · Alankrita Taneja

  Frontiers in Hematology

  doi 10.3389/frhem.2025.1730554

• Original Research

  Published 21 November 2025

  Oral medication treatment patterns in blepharospasm and Meige syndrome: a multi-institutional TriNetX study

  Rachel J. Heo · Nitai Mukhopadhyay · Caileigh Dintino · Ahmed Negida · Matthew J. Barrett · Brian D. Berman

  Dystonia

  doi 10.3389/dyst.2025.15368